Becker's Healthcare March 14, 2024
Support is growing for a little-known psychedelic drug called ibogaine that could help people overcome addiction, but concerns over its impact on the heart remain, The Washington Post reported March 14.
Ibogaine is an extract from an African shrub called Tabernanthe iboga. It grows in the Central African rainforest and has been used in traditional medicine as a mild stimulant and in religious ceremonies. The psychedelic promotes growth of neural networks in damaged brains, Deborah Mash, founder of DemeRx, a company developing addiction treatments derived from ibogaine compounds, told the Post. Drug users who take it to reduce their addiction to other substances do not feel cravings or withdrawal symptoms, and their mood improves, she said.
The interest in using...
Today's Sponsors
Today's Sponsor